Executive Vice President and Chief Financial Officer
Dominic joined Ferring in April 2017 as Chief Financial Officer, and is responsible for finance, IT, procurement, and internal audit. Also, he is executive sponsor of the business process re-engineering program, and co-chairman of the FerGene.
Dominic has over 30 years’ finance and business experience in the life sciences industry. Previously, he worked for 4 years at Takeda Pharmaceuticals as Global Financial Controller, and CFO of the international business following the acquisition of Nycomed. Prior to this, he worked for Hoffmann-La Roche for 13 years, where he was CFO of the Pharma Division for 9 years during a period of transformation and growth. During this time, he was engaged in numerous strategic initiatives and business transactions, as well as their operational implications, culminating in the privatisation of Genentech in the US in 2009. Earlier in his career he worked for Price Waterhouse in Manchester.
Dominic is a Fellow of the Institute of Chartered Accountants in England and Wales (FCA), and has a BSc in Chemistry from the University of Nottingham.